Bibliography
- Zupancic M, Shah PC, Shah-Khan F. Gemcitabine – associated thrombotic thrombocytopenic purpura. Lancet Oncol 2007;8(7):634-41
- De Smet D, Jochmans K, Neeyns B. Development of thrombotic thrombopenic purpura after a single dose of gemcitabine. Ann Hematol 2008;87(6):495-6
- Humphreys BD, Sharman JP, Henderson JM, et al. Gemcitabine – associated thrombotic microangiopathy. Cancer 2004;100(12):2664-70
- Thachil J. Causes of thrombotic thrombocytopenic purpura. Lancet Oncol 2007;8(9):757-8
- Rieger M, Mannucci PM, Kremer Hovinga JA, et al. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 2005;106:1262-7
- Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84
- Moake JL. Moschcowitz, multimers, and metalloprotease. N Engl J Med 1998;339:1629-31
- van der Heijden M, Ackland SP, Deveridge S. Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy—a case report and review of the literature. Acta Oncol 1998;37:107-9
- Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600
- Raife TJ, Lager DJ. Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects. Mayo Clin Proc 2002;77:323-8
- Jimenez JJ, Jy W, Mauro LM, et al. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003;123:896-902
- Ballermann BJ. Endothelial cell activation. Kidney Int 1998;53:1810-26
- Schieppati A, Ruggenenti P, Cornejo RP, et al. Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian registry of haemolytic uremic syndrome. J Am Soc Nephrol 1992;2:1640-4
- Melnyk AM, Solez K, Kjellstrand CM. Adult hemolytic-uremic syndrome. A review of 37 cases. Arch Intern Med 1995;155:2077-84
- Lohrmann HP, Adam W, Heymer B, Kubanek B. Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases. Ann Intern Med 1973;79:368-75
- Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991;325:398-403
- Neild GH. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: pathophysiology and treatment. Kidney Int 1998;64:S45-9
- Allford SL, Hunt BJ, Rose P, Machin SJ. Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003;120:556-73
- Izzedine H, Launay-Vacher V, Mercadal L, et al. Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy. Am J Hematol 2004;77:319